	How An Inversion Is Paying Off Twice In Mylan's Fight Against Teva Pharmaceutical - Forbes
	Think EpiPen is Mylan's first scandal? Here's a timeline of jet use, an unearned MBA and more - Fierce Pharma
	Mylan to launch generic version of EpiPen, at half the cost
	Did Mylan Just Cut the Price of the EpiPen? Not Really
	Mylan CEO saw more than 600% pay increase as company repeatedly raised EpiPen price - New York Daily News
	Mylan recalled three blood pressure medications that had impurities - USA TODAY
	Pharmaceutical firm Mylan will pay up to $335M over opioid crisis
	Mylan: Undervalued Pharmaceutical Company With Potential Near-Term Fundamental Catalysts - Seeking Alpha